{"pmid":32491306,"title":"The different tests for the diagnosis of COVID-19 - A review in Brazil so far.","text":["The different tests for the diagnosis of COVID-19 - A review in Brazil so far.","SARS-CoV-2 is a novel virus from the coronavirus family that emerged in the end of December 2019 in Wuhan, China. The virus is now widespread and causing the current pandemic of COVID-19, a highly pathogenic viral pneumonia, commonly presented with fever and cough, which frequently lead to lower respiratory tract disease with poor clinical outcomes associated with older age and underlying health conditions. Supportive care for patients is typically the standard protocol because no specific effective antiviral therapies have been identified so far. The current outbreak is challenging governments and health authorities all over the world. In here we present a comparison among the current diagnostic tools and kits being used to test Brazilian population.","JBRA Assist Reprod","Laureano, Ana Flavia Santarine","Riboldi, Marcia","32491306"],"abstract":["SARS-CoV-2 is a novel virus from the coronavirus family that emerged in the end of December 2019 in Wuhan, China. The virus is now widespread and causing the current pandemic of COVID-19, a highly pathogenic viral pneumonia, commonly presented with fever and cough, which frequently lead to lower respiratory tract disease with poor clinical outcomes associated with older age and underlying health conditions. Supportive care for patients is typically the standard protocol because no specific effective antiviral therapies have been identified so far. The current outbreak is challenging governments and health authorities all over the world. In here we present a comparison among the current diagnostic tools and kits being used to test Brazilian population."],"journal":"JBRA Assist Reprod","authors":["Laureano, Ana Flavia Santarine","Riboldi, Marcia"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32491306","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.5935/1518-0557.20200046","keywords":["covid-19","elisa","immunochromatography","pcr","diagnostic tool"],"locations":["Wuhan","China","Brazilian","Brazil"],"countries":["China","Brazil"],"countries_codes":["CHN|China","BRA|Brazil"],"topics":["Diagnosis"],"weight":1,"_version_":1668892169328394240,"score":9.490897,"similar":[{"pmid":32376546,"pmcid":"PMC7086127","title":"[Laboratory testing techniques for SARS-CoV-2].","text":["[Laboratory testing techniques for SARS-CoV-2].","The ongoing epidemic of caused by the coronavirus SARS-CoV-2 starting in December 2019 poses a serious public health threat globally. The virus is highly infectious and transmitted mainly through droplets and contacts, and is associated with a high risk of pneumonia. A small number of patients may present with acute respiratory distress syndrome with severe respiratory complications, which can lead even to death. The selection of appropriate detection techniques and methods for accurate and rapid identification of pathogens therefore plays a key role in improving the diagnosis and treatment of the patients and containing the outbreak. In this review, the authors gives an overview of the virus laboratory detection technology, including virus isolation and culture, real-time fluorescent PCR, gene sequencing, serological antibody detection, and the gene editing technology based on CRISPR/Cas13 system. These techniques are expected to provide valuable assistance in controlling the epidemic and new ideas for future researches.","Nan Fang Yi Ke Da Xue Xue Bao","Qiu, Feng","Wang, Huijun","Zhang, Zikang","Cao, Longbin","Wang, Chenlong","Wu, Jingbiao","Du, Qingfeng","32376546"],"abstract":["The ongoing epidemic of caused by the coronavirus SARS-CoV-2 starting in December 2019 poses a serious public health threat globally. The virus is highly infectious and transmitted mainly through droplets and contacts, and is associated with a high risk of pneumonia. A small number of patients may present with acute respiratory distress syndrome with severe respiratory complications, which can lead even to death. The selection of appropriate detection techniques and methods for accurate and rapid identification of pathogens therefore plays a key role in improving the diagnosis and treatment of the patients and containing the outbreak. In this review, the authors gives an overview of the virus laboratory detection technology, including virus isolation and culture, real-time fluorescent PCR, gene sequencing, serological antibody detection, and the gene editing technology based on CRISPR/Cas13 system. These techniques are expected to provide valuable assistance in controlling the epidemic and new ideas for future researches."],"journal":"Nan Fang Yi Ke Da Xue Xue Bao","authors":["Qiu, Feng","Wang, Huijun","Zhang, Zikang","Cao, Longbin","Wang, Chenlong","Wu, Jingbiao","Du, Qingfeng"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376546","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12122/j.issn.1673-4254.2020.02.04","keywords":["covid-19","pcr","sars-cov-2","gene editing"],"topics":["Diagnosis"],"weight":1,"_version_":1666597097457057792,"score":137.32327},{"pmid":32132196,"pmcid":"PMC7180250","title":"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens.","text":["Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens.","On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 x 10(4) RNA copies/ml (range, 2.21 x 10(2) to 4.71 x 10(5) RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.","J Clin Microbiol","Chan, Jasper Fuk-Woo","Yip, Cyril Chik-Yan","To, Kelvin Kai-Wang","Tang, Tommy Hing-Cheung","Wong, Sally Cheuk-Ying","Leung, Kit-Hang","Fung, Agnes Yim-Fong","Ng, Anthony Chin-Ki","Zou, Zijiao","Tsoi, Hoi-Wah","Choi, Garnet Kwan-Yue","Tam, Anthony Raymond","Cheng, Vincent Chi-Chung","Chan, Kwok-Hung","Tsang, Owen Tak-Yin","Yuen, Kwok-Yung","32132196"],"abstract":["On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 x 10(4) RNA copies/ml (range, 2.21 x 10(2) to 4.71 x 10(5) RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19."],"journal":"J Clin Microbiol","authors":["Chan, Jasper Fuk-Woo","Yip, Cyril Chik-Yan","To, Kelvin Kai-Wang","Tang, Tommy Hing-Cheung","Wong, Sally Cheuk-Ying","Leung, Kit-Hang","Fung, Agnes Yim-Fong","Ng, Anthony Chin-Ki","Zou, Zijiao","Tsoi, Hoi-Wah","Choi, Garnet Kwan-Yue","Tam, Anthony Raymond","Cheng, Vincent Chi-Chung","Chan, Kwok-Hung","Tsang, Owen Tak-Yin","Yuen, Kwok-Yung"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32132196","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.1128/JCM.00310-20","keywords":["covid-19","pcr","sars","wuhan","coronavirus","diagnostic","emerging","virus"],"locations":["Wuhan","China","China","RdRp","Vitro"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138492785131521,"score":132.8604},{"pmid":32245083,"pmcid":"PMC7157541","title":"SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","text":["SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.","In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.","Pathogens","Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D","32245083"],"abstract":["In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes."],"journal":"Pathogens","authors":["Rabi, Firas A","Al Zoubi, Mazhar S","Kasasbeh, Ghena A","Salameh, Dunia M","Al-Nasser, Amjad D"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245083","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.3390/pathogens9030231","keywords":["covid-19","coronavirus","sars","sars-cov-2","wuhan","pandemic"],"locations":["Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment","Diagnosis"],"weight":1,"_version_":1666138492019671040,"score":130.03664},{"pmid":32139372,"pmcid":"PMC7081812","title":"What we know so far: COVID-19 current clinical knowledge and research.","text":["What we know so far: COVID-19 current clinical knowledge and research.","In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.","Clin Med (Lond)","Lake, Mary A","32139372"],"abstract":["In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features."],"journal":"Clin Med (Lond)","authors":["Lake, Mary A"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32139372","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.7861/clinmed.2019-coron","keywords":["2019-ncov","sars-cov-2","wuhan","coronavirus","respiratory tract infection"],"locations":["Wuhan","China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Transmission","Prevention"],"weight":1,"_version_":1666138490700562432,"score":129.75487},{"pmid":32344679,"title":"The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control.","text":["The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control.","A pneumonia outbreak with unknown etiology was reported in Wuhan, Hubei province, China, in December 2019, associated with the Huanan Seafood Wholesale Market. The causative agent of the outbreak was identified by the WHO as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), producing the disease named coronavirus disease-2019 (COVID-19). The virus is closely related (96.3%) to bat coronavirus RaTG13, based on phylogenetic analysis. Human-to-human transmission has been confirmed even from asymptomatic carriers. The virus has spread to at least 200 countries, and more than 1,700,000 confirmed cases and 111,600 deaths have been recorded, with massive global increases in the number of cases daily. Therefore, the WHO has declared COVID-19 a pandemic. The disease is characterized by fever, dry cough, and chest pain with pneumonia in severe cases. In the beginning, the world public health authorities tried to eradicate the disease in China through quarantine but are now transitioning to prevention strategies worldwide to delay its spread. To date, there are no available vaccines or specific therapeutic drugs to treat the virus. There are many knowledge gaps about the newly emerged SARS-CoV-2, leading to misinformation. Therefore, in this review, we provide recent information about the COVID-19 pandemic. This review also provides insights for the control of pathogenic infections in humans such as SARS-CoV-2 infection and future spillovers.","J Clin Med","Helmy, Yosra A","Fawzy, Mohamed","Elaswad, Ahmed","Sobieh, Ahmed","Kenney, Scott P","Shehata, Awad A","32344679"],"abstract":["A pneumonia outbreak with unknown etiology was reported in Wuhan, Hubei province, China, in December 2019, associated with the Huanan Seafood Wholesale Market. The causative agent of the outbreak was identified by the WHO as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), producing the disease named coronavirus disease-2019 (COVID-19). The virus is closely related (96.3%) to bat coronavirus RaTG13, based on phylogenetic analysis. Human-to-human transmission has been confirmed even from asymptomatic carriers. The virus has spread to at least 200 countries, and more than 1,700,000 confirmed cases and 111,600 deaths have been recorded, with massive global increases in the number of cases daily. Therefore, the WHO has declared COVID-19 a pandemic. The disease is characterized by fever, dry cough, and chest pain with pneumonia in severe cases. In the beginning, the world public health authorities tried to eradicate the disease in China through quarantine but are now transitioning to prevention strategies worldwide to delay its spread. To date, there are no available vaccines or specific therapeutic drugs to treat the virus. There are many knowledge gaps about the newly emerged SARS-CoV-2, leading to misinformation. Therefore, in this review, we provide recent information about the COVID-19 pandemic. This review also provides insights for the control of pathogenic infections in humans such as SARS-CoV-2 infection and future spillovers."],"journal":"J Clin Med","authors":["Helmy, Yosra A","Fawzy, Mohamed","Elaswad, Ahmed","Sobieh, Ahmed","Kenney, Scott P","Shehata, Awad A"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32344679","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3390/jcm9041225","keywords":["covid-19","one health","sars-cov-2","control","diagnosis","epidemiology","genetics","outbreak","pneumonia","public health","treatment"],"locations":["Wuhan","Hubei","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis","Mechanism"],"weight":1,"_version_":1666138494922129408,"score":127.0433}]}